Skip to main content
Figure 3 | Critical Care

Figure 3

From: Effect of tyrosine kinase inhibitors, imatinib and nilotinib, in murine lipopolysaccharide-induced acute lung injury during neutropenia recovery

Figure 3

Effect of imatinib or nilotinib on lung edema in mice with lipoplysaccharide-induced acute lung injury. After lipopolysaccharide (LPS) administration, treatment with imatinib or nilotinib markedly decreased (A) lung wet/dry (W/D) weight ratio and (B) albumin. The lower lobe of the right lung was removed and weighed (wet weight), dried at 60°C for 72 hrs, and weighed again (dry weight). The W/D ratio was used as an indicator of lung edema formation. C, cyclophosphamide; I, imatinib; N, nilotinib. Asterisks indicates significant differences to the C + LPS group (*P <0.05, **P <0.01).

Back to article page

Critical Care

ISSN: 1364-8535